Clinical Trial Detail

NCT ID NCT02311582
Title MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

glioblastoma multiforme

malignant glioma

Therapies

Pembrolizumab

Age Groups: adult

No variant requirements are available.